184 related articles for article (PubMed ID: 36600585)
1. Effect of renin-angiotensin system inhibitors in patients with cancer treated with anti-VEGF therapy.
Moriyama S; Hieda M; Kisanuki M; Kawano S; Yokoyama T; Fukata M; Kusaba H; Maruyama T; Baba E; Akashi K; Fukuda H
Open Heart; 2022 Dec; 9(2):. PubMed ID: 36600585
[TBL] [Abstract][Full Text] [Related]
2. Renin-Angiotensin System Inhibitors and Major Cardiovascular Events after Sepsis.
Angriman F; Rosella LC; Lawler PR; Ko DT; Martin CM; Wunsch H; Scales DC
Ann Am Thorac Soc; 2023 Mar; 20(3):414-423. PubMed ID: 36251422
[No Abstract] [Full Text] [Related]
3. Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors.
Nuzzo PV; Adib E; Weise N; Curran C; Stewart T; Freeman D; Nassar AH; Abou Alaiwi S; Bakouny Z; McGregor BA; Choueiri TK; Jain RK; McKay RR; Sonpavde G
Clin Genitourin Cancer; 2022 Aug; 20(4):301-306. PubMed ID: 35614012
[TBL] [Abstract][Full Text] [Related]
4. Impact of early initiation of renin-angiotensin blockade on renal function and clinical outcomes in patients with hypertensive emergency: a retrospective cohort study.
Endo K; Hayashi K; Hara Y; Miyake A; Takano K; Horikawa T; Yoshino K; Sakai M; Kitamura K; Ito S; Imai N; Fujitani S; Suzuki T
BMC Nephrol; 2023 Mar; 24(1):68. PubMed ID: 36949416
[TBL] [Abstract][Full Text] [Related]
5. Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer.
Zeman M; Skałba W; Wilk AM; Cortez AJ; Maciejewski A; Czarniecka A
BMC Cancer; 2022 Jul; 22(1):815. PubMed ID: 35879682
[TBL] [Abstract][Full Text] [Related]
6. Impact of Renin-angiotensin System Inhibitors on the Efficacy of Anti-PD-1/PD-L1 Antibodies in NSCLC Patients.
Tozuka T; Yanagitani N; Yoshida H; Manabe R; Ogusu S; Tsugitomi R; Sakamoto H; Amino Y; Ariyasu R; Uchibori K; Kitazono S; Seike M; Gemma A; Nishio M
Anticancer Res; 2021 Apr; 41(4):2093-2100. PubMed ID: 33813419
[TBL] [Abstract][Full Text] [Related]
7. Treatment effects of renin-angiotensin system inhibitor and calcium channel blocker in patients with coronary artery narrowing (from the Japanese Coronary Artery Disease Study).
Fujita M; Sasayama S; Terasaki F; Mitani S; Morimoto T; Yamazaki T; Hayashi D; Kohro T; Okada Y; Nagai R;
Heart Vessels; 2010 Nov; 25(6):453-9. PubMed ID: 20922538
[TBL] [Abstract][Full Text] [Related]
8. Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension.
Gnanenthiran SR; Borghi C; Burger D; Caramelli B; Charchar F; Chirinos JA; Cohen JB; Cremer A; Di Tanna GL; Duvignaud A; Freilich D; Gommans DHF; Gracia-Ramos AE; Murray TA; Pelorosso F; Poulter NR; Puskarich MA; Rizas KD; Rothlin R; Schlaich MP; Schreinlecher M; Steckelings UM; Sharma A; Stergiou GS; Tignanelli CJ; Tomaszewski M; Unger T; van Kimmenade RRJ; Wainford RD; Williams B; Rodgers A; Schutte AE;
J Am Heart Assoc; 2022 Sep; 11(17):e026143. PubMed ID: 36000426
[TBL] [Abstract][Full Text] [Related]
9. Risk of Developing Hypokalemia in Patients With Hypertension Treated With Combination Antihypertensive Therapy.
Krogager ML; Mortensen RN; Lund PE; Bøggild H; Hansen SM; Kragholm K; Aasbjerg K; Søgaard P; Torp-Pedersen C
Hypertension; 2020 Apr; 75(4):966-972. PubMed ID: 32114850
[TBL] [Abstract][Full Text] [Related]
10. Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation.
Fischer-Rasokat U; Bänsch C; Renker M; Rolf A; Charitos EI; Weferling M; Liebetrau C; Herrmann E; Choi YH; Hamm CW; Kim WK
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):815-824. PubMed ID: 35441662
[TBL] [Abstract][Full Text] [Related]
11. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
12. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
Hsiao FC; Tung YC; Chou SH; Wu LS; Lin CP; Wang CL; Lin YS; Chang CJ; Chu PH
Medicine (Baltimore); 2015 Dec; 94(51):e2355. PubMed ID: 26705234
[TBL] [Abstract][Full Text] [Related]
13. Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk.
Liu JC; Hsu YP; Wu SY
PLoS One; 2016; 11(9):e0162588. PubMed ID: 27632175
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of angiotensin receptor-neprilysin inhibitors and thiazide diuretic/renin-angiotensin system inhibitor combination therapy in hypertensive patients: a retrospective cohort study.
Mitsuno R; Uchiyama K; Nakayama T; Takahashi R; Yoshimoto N; Yamaguchi S; Washida N; Kanda T; Hayashi K; Itoh H
J Hum Hypertens; 2023 Dec; 37(12):1049-1055. PubMed ID: 37488277
[TBL] [Abstract][Full Text] [Related]
15. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
Moriyama T; Nakayama K; Ochi A; Amemiya N; Tsuruta Y; Kojima C; Itabashi M; Takei T; Uchida K; Nitta K
Clin Exp Nephrol; 2012 Apr; 16(2):231-7. PubMed ID: 22038185
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study.
Zhu XX; Li JH; Fang P; Qu XF; Liang LJ; Lai JM; Yin XY
BMC Cancer; 2023 Sep; 23(1):826. PubMed ID: 37670280
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM
J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739
[TBL] [Abstract][Full Text] [Related]
18. Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
Yue C; Li G; Wen Y; Li X; Gao R
J Rheumatol; 2018 May; 45(5):655-662. PubMed ID: 29449503
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
[TBL] [Abstract][Full Text] [Related]
20. Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019).
Yang A; Wu H; Lau ESH; Shi M; Fan B; Kong AP; Ma RC; Luk AO; Chan JC; Chow E
EBioMedicine; 2022 Sep; 83():104219. PubMed ID: 35970023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
